Icon (ICLR) Tax Provisions (2009 - 2026)
Icon's (ICLR) quarterly Tax Provisions came in at -$19.6 million in Q2 2026, down 194.88% year-over-year from $20.7 million in Q2 2025, and up 14.0% quarter-over-quarter from -$22.8 million in Q1 2026.
Analysis
Icon (ICLR) Tax Provisions (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Tax Provisions for 18 consecutive years, with -$19.6 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Tax Provisions fell 194.88% year-over-year to -$19.6 million in Q2 2026; TTM through Jun 2026 was -$88.8 million, a 264.84% decrease from a year earlier, with the FY2025 full-year figure at -$58.0 million, up 40.09% from the prior year.
- Tax Provisions was -$19.6 million for Q2 2026 at Icon, up from -$22.8 million in the prior quarter.
- Over five years, Tax Provisions peaked at $20.7 million in Q2 2025 and troughed at -$37.4 million in Q3 2024.
- A 5-year average of -$9.3 million and a median of -$13.8 million in 2022 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions slumped 689.73% in 2022 and soared 276.5% in 2023, its largest moves.
- Over 5 years, Tax Provisions stood at -$10.9 million in 2022, then soared by 276.5% to $19.2 million in 2023, then sank by 33.39% to $12.8 million in 2024, then slumped by 183.48% to -$10.7 million in 2025, then tumbled by 84.04% to -$19.6 million in 2026.
- The last three Tax Provisions figures came in at -$19.6 million (Q2 2026), -$22.8 million (Q1 2026), and -$10.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 60.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 30.30 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -19.62 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 53.93 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 12.00 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 128,000.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 11,000.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -113.32 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 3,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19.62 Mn |
| Mar 31, 2026 | -22.81 Mn |
| Dec 31, 2025 | -10.66 Mn |
| Sep 30, 2025 | -35.75 Mn |
| Jun 30, 2025 | 20.67 Mn |
| Mar 31, 2025 | -20.35 Mn |
| Dec 31, 2024 | 12.77 Mn |
| Sep 30, 2024 | -37.44 Mn |
| Jun 30, 2024 | -23.34 Mn |
| Mar 31, 2024 | -28.32 Mn |
| Dec 31, 2023 | 19.17 Mn |
| Sep 30, 2023 | 16.38 Mn |
| Jun 30, 2023 | 8.27 Mn |
| Mar 31, 2023 | 12.90 Mn |
| Dec 31, 2022 | -10.86 Mn |
| Sep 30, 2022 | -21.01 Mn |
| Jun 30, 2022 | -14.25 Mn |
| Mar 31, 2022 | -13.29 Mn |
| Dec 31, 2021 | -14.62 Mn |
| Sep 30, 2021 | 3.56 Mn |